Formulary decision guide

View all stories of the same content type.

  • Final version_Jardiance FDG update
    Formulary decision guide

    Jardiance® (empagliflozin) film-coated tablets

    Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

    This formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice. View prescribing information Key points on this medicine Jardiance: is a once-daily SGLT2 inhibitor that improves ...

  • Stalpex UPDATE_v2
    Formulary decision guide

    Stalpex (salmeterol xinafoate/fluticasone propionate)

    2019-05-08T08:03:00Z Commissioned by Glenmark Pharmaceuticals Europe Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Stalpex is a branded generic inhaled ...

  • Final version - Nutramigen 1,2 & 3 FDG
    Formulary decision guide

    Nutramigen™ 1, 2 & 3 with LGG®

    2019-04-18T13:58:00Z Commissioned by Mead Johnson Nutrition

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice . Key points CMA is the most common childhood food allergy affecting 1.9–⁠4.9% of infants ...

  • Soprobec FDG final image
    Formulary decision guide

    Soprobec (beclometasone dipropionate) pMDI

    2019-04-04T07:32:00Z Commissioned by Glenmark Pharmaceuticals Europe Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Soprobec is a generic CFC-free beclometasone ...

  • 20190319 Symbicort FDG Online thumbnail
    Formulary decision guide

    Symbicort® (budesonide/formoterol) for COPD

    Commissioned by AstraZeneca

    Information intended for healthcare professionals only. This formulary decision guide was commissioned by AstraZeneca UK Ltd, who had full editorial control, and was produced in a format developed by Guidelines in Practice . Indications Symbicort pMDI 200 μg/6 μg per actuation, pressurised inhalation suspension, Symbicort ...

  • Puramino FDG image final
    Formulary decision guide

    Nutramigen™ PURAMINO™

    2019-03-14T11:37:00Z Commissioned by Mead Johnson Nutrition

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition Ltd in a format developed by Guidelines in Practice . Key points Cow’s milk allergy (CMA) is a common yet complex food allergy, ...

  • FDG - Methofill
    Formulary decision guide

    Methofill® (methotrexate) Self Inject

    2019-02-18T08:26:00Z Commissioned by Accord UK Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Accord UK Ltd in a format developed by Guidelines in Practice . View prescribing and adverse event reporting information here Key points Methofill ® ...

  • Formulary decision guide: Amgevita (adalimumab biosimilar)
    Formulary decision guide

    Semglee® ▼ (insulin glargine biosimilar)

    2019-01-07T08:39:00Z Commissioned by Mylan

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Comparative pharmacokinetic and pharmacodynamic studies have demonstrated the ...

  • Spiriva Respimat FDG
    Formulary decision guide

    Spiriva® Respimat® (tiotropium)

    2018-12-12T11:44:00Z Commissioned by Boehringer Ingelheim Limited

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Boehringer Ingelheim Limited in a format developed by Guidelines in Practice . Boehringer Ingelheim Limited reviewed the content for compliance with the ABPI code of practice. View prescribing information here ...

  • Formulary decision guide: Semglee (insulin glargine biosimilar)
    Formulary decision guide

    Formulary decision guide: Hulio® ▼ (adalimumab biosimilar)

    2018-10-31T09:24:00Z Commissioned by Mylan

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice. It has been reviewed by a medicines management professional. View prescribing information here